1. The effect of drugs that cause neutropenia has been tested upon normal bone marrow colony formation in semi-solid agar.
or idiosyncratic mechanisms would have no effect. We have tested this proposition with six drugs which can cause neutropenia in vivo.
There is some evidence that chloramphenicol depresses the [14C]formate incorporation into DNA and RNA of bone marrow cells taken from patients who have recovered from chloramphenicol-induced aplastic anaemia to agreater degree than incontrolbonemarrow (Yunis, 1969) . This suggests that the cells are abnormally sensitive to this drug. We have developed a reproducible bioassay for the effect of chloramphenicol upon normal bone marrow in vitro by assessingthe inhibition of colony formation in semi-solid agar. This allows the effect of chloramphenicol in vitro on the bone marrow of patients who have recovered from neutropenia or aplastic anaemia to be observed.
Some of these results have been the subject of a preliminary communication (Howell, Andrews &Watts, 1973) .
M E T H O D S

Cell culture
Human bone marrow cells were cultured in semi-solid agar on a hard agar underlay by a modification of the technique of Pike & Robinson (1970) . Aliquots (1 ml) of equal volumes of 1% agar and double-strength modified Eagle's medium, containing 18% foetal bovine serum (Bradley & Metcalfe, 1966) , were pipetted into 30 mm plastic Petri dishes (Sterilin), together with lo6 human peripheral blood leucocytes, as a source of colony-stimulating factor, and 0.1 ml of the test drug. Aliquots (1 ml) of equal volumes of 0.6% agar and double-strength Eagle's medium with 2 x lo5 normal human bone marrow cells were pipetted over the basal agar layer and allowed to gel at room temperature for 10 min.
The modified Eagle's medium used in these experiments contains : Eagle's minimum essential medium (M.E.M.) ( x 10) (Flow Laboratories Ltd, Irvine, Scotland), 14-5 ml; Eagle's M.E.M vitamins ( x loo), 2.9 ml; Eagle's M.E.M. amino acids ( x loo), 2.9 ml; Eagle's M.E.M. nonessential amino acids [ x loo), 1.45 ml; sodium pyruvate (0.2 moll-'), 1.45 ml; asparagine (3.7 x lo-' mol 1-I), 0-8 ml; serine (9.5 x lo-' mol 1-I), 0-2 ml; sodium bicarbonate (0-52 mol I-'), 8.2 1; distilled water, 11 ml; glutamine (0.2 rnol 1-I), 2 ml; Trypticase Soy Broth (Baltimore Biological Laboratory) (30 g 1-I), 18 ml; foetal bovine serum (Flow), 36 ml; benzylpenicillin (lo8 units Peripheral blood was collected into syringes treated with preservative-free heparin (I : 1000). The blood was allowed to sediment in the syringe under gravity for up to 2 h, the supernatant plasma and leucocytes were removed and washed twice in Liebovitz L15 tissue culture medium (Flow) before counting and then mixing with agar and medium for the under layers. Bone marrow cells, obtained either by sternal aspiration from normal volunteers (A.H., T.M.A.) or from ribs removed at thoracotomy, were suspended in heparinized foetal bovine serum and allowed to sediment for up to 2 h before removing the supernatant plasma and cells. These cells were washed twice in L15 medium before mixing with the agar medium for the upper layer.
Drugs were made up as 10 mmol 1-' solutions in phosphate-buffered saline, pH 7.4, except for phenylbutazone which was made up in Tris buffer, pH 8.4, and the pH adjusted to 7.6 by adding 2 moll-' HCl. Dilutions (0.1 ml IOmmol 1-1 to0~02mmol1-') of each drug were added to the under layer. Phosphate-buffered saline was used in the control cultures except in the and streptomycin (0-2 mol I-'), 0-2 ml. experiments with phenylbutazone when Tris buffer (pH 7.6; 0.1 ml) was employed. All dilutions and controls were tested at least in triplicate.
The effect of chloramphenicol on murine bone marrow cells, murine L cells (Flow) and human Hela cells (Difco) growing in the agar culture system was also investigated.
Mice, 2-3 months old (CBA/Ca inbred strain, maintained at the Clinical Research Centre), were killed by cervical dislocation and the bone marrow was flushed from the femora with L15 medium. The cells were washed twice in L15 medium before counting and adding to the upper agar layer at a final concentration of 2 x lo5 cells/ml. An extract (0.1 ml) of pregnant mouse uterus prepared according to the method of Bradley et al. (1971) was used as a source of colony-stimulating factor. L cells and Hela cells form colonies in agar without added colonystimulating factor. One hundred cells were added to each Petri dish. The plating efficiencies were 28% and 35% for L cells and Hela cells respectively.
All cell types were incubated at 37°C in sealed and humidified plastic boxes containing 10% CO, in air. The colonies were counted with an inverted microscope when the human marrow cells had been incubated for 14 days and all other cell types for 7 days, A group of more than fifty cells was counted as a colony for bone marrow cells, and a group of more than ten cells was counted as a colony for the L cell and Hela cell cultures. Cell morphology was assessed by removing colonies from the agar with haematocrit tubes and staining on slides with acetoorcein. Human colonies contained predominantly granulocytes or a mixture of granulocytes, monocytes and their precursors. Murine colonies were predominantly macrophages with occasional mixed and purely granulocyte colonies.
Statistical analysis
Percentage inhibition of colony formation was defined as estimated no. of initial colonies -no. of final colonies
x 100 estimated no. of initial colonies
The percentage inhibition of colony formation is related to log concentration of drug by a sigmoid dose-response curve, with inhibition ranging from 0 to 100%. The usual method of fiitting a curve of this type involves transforming the percentage inhibition to a 'probit' or normal equivalent deviate (NED) and performing a weighted regression of NED on log concentration (Finney, 1971) . In our experiments the percentages of inhibition were not known precisely, as the denominator, the number of colonies formed in the absence of drug, is variable, Several controls were used in each experiment ; it would be possible to arrange the data as above by expressing response as a percentage of the mean of the controls. A more precise analysis is made by including the mean of the number of colonies formed in the absence of drug as a parameter of the fitted curve, which has to be estimated at the same time as the parameters of the regression line, using methods developed by Wadley (1949) and Finney
(1 971).
Comparisons of toxicities of drugs, and in this case sensitivities of cells, are simplest when the NED regression lines corresponding to the dose-response curves are parallel. Parallelism of the regression lines for a group of experiments was tested by comparing two x2 values for goodness of fit, the first obtained by fitting independent regression lines as above, the second by fitting separate but parallel lines to all sets of data. If a dose-response curve is reproducible, regression lines obtained from experiments using the same drug and type of cell should be coincident. The x2 value obtained from the parallel lines was compared with that found by fitting one regression line for all similar experiments. Control values depended on the culture conditions; the mean number of colonies formed in the absence of drug was estimated for each experiment.
The analysis was carried out using the mean number of colonies formed for each concentration of drug; the value of x2 obtained was compared with a second value calculated from the individual observations to test for departures from the underlying model (Finney, 1971) .
RESULTS
The observed effects of phenylbutazone, methimazole, thiouracil, chloramphenicol, B-mercaptopurine and sodium aurothiomalate upon human bonemarrow colony formation are shown in Fig. 1 . The first three drugs have little or no effect whereas there is marked depression of colony formation with chloramphenicol, 6-mercaptopurine and sodium aurothiomalate at or below concentrations found in serum during therapy. Fig. 2 , with therapeutic plasma concentrations shaded. The corresponding regression line of NED on log concentration is shown in Fig. 3 , with its 95% fiducial limits.
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FIG. 2. Relation between inhibition of colony formation, expressed as a percentage of estimated natural growth, and concentration of chloramphenicol. The therapeutic plasma concentration is shaded.
The estimates of the parameters of theindividual dose-response curves are shown in Table 1 and the regression lines are shown graphically in Fig. 4 . The slopes of the regression lines for the three experiments with mouse bone marrow cells were not significantly different (P = 0.17) and a single regression line did not show a significantly worse fit than the parallel lines (P = 0.27). Similarly one line was sufficient to describe the two experiments with human bone marrow cells, although the test for lack of coincidence gave a result which was almost significant at the 5% level. A single regression line could also be fitted to all four sets of data from mouse cells including the experiment with L cells; the response of Hela cells was not significantly different from human marrow cells. The mean line for human cells, and that for murine cells, are shown in Fig. 4 . However, the slopes of the regression lines from the human marrow cell data were significantly greater than those for the murine cells (P<O-01) .
The estimates of ED,, (median effective dose producing 50% inhibition of growth) are shown in Fig. 5 . When two regression lines are parallel the ratio of the ED,, values is a measure of relative sensitivity of the cells (and comparison of the ED,, values is equivalent to testing for coincidence of the regression lines). As the regression lines for human cells were not parallel to those for murine cells the relative sensitivity changes as the drug concentration increases. Fig. 4 shows that for lower concentrations of drug mouse cells are more sensitive to chloramphenicol than human cells, but that there is little difference at the higher concentrations.
D I S C U S S I O N
Chloramphenicol inhibits colony formation by human bone marrow cells in vitro at concentrations found in serum during therapy (Goodman & Gilman, 1970) . This inhibitory effect is not confined to human marrow nor to marrow cells only, since mouse bone marrow, mouse L cell and human Hela cell proliferation is also reduced in culture. In short-term tissue culture experiments, inhibition of proliferation of bone marrow occurs only at very high chloramphenicol concentrations (>300 pmol I-') (Yunis & Harrington, 1960; Ward, 1966) whereas low doses of chloramphenicol inhibit protein synthesis in bone marrow (Djordjevic & Szybalski, 1960) and myeloma cell proliferation (Harman, Petergell & Sorenson, 1969) if the culture period is prolonged beyond 24 h as was the case in our experiments. Scott, Finegold, Belthin & Lawrence (1965) found that granulocyte depression occurred in patients treated for more than 14 days and if the plasma chloramphenicol concentrations were consistently above 75 pmoll-l. Bone marrow culture in agar mimics this time-course and inhibition of proliferation occurs at similar drug concentrations.
Chloramphenicol primarily affects mammalian cells in rapidly dividing tissues. It depresses haemopoiesis and is immunosuppressive in vivo (Weisberger, Moore & Schoenberg, 1966) and in vitro (Ambrose & Coons, 1963) . However, it does not inhibit beating rat heart cells in tissue culture (Kroon & Jansen, 1968) nor protein synthesis in non-dividing lymphocytes (Smith & Forbes, 1967) . Mouse cells are more sensitive than human cells over most of the range of concentrations used in our experiments; this may be due to the difference in the generation times of mouse and human marrow or to other species differences. The generation time for mouse bone marrow is approximately 12-15 h (Bsyum & Breivik, 1973; Testa & Lord, 1973) , whereas estimates of the generation time for human marrow vary from 24 h (Stryckmans Cronkite, Fache, Fliedner & Ramos, 1966) to 52 h (Cronkite & Vincent, 1969) .
Two types of bone marrow depression occur in association with chloramphenicol treatment (Yunis, 1969) . One is relatively common, dose-dependent, occurs during therapy, is reversible and thought to be caused by inhibition of mitochondria1 protein synthesis (Martels, Maryan, Smith & Yunis, 1969) . The other is rare, non-dose-dependent, usually occurs after a course of therapy, and may be secondary to a biochemical defect in the patient's cells (Yunis, 1969) . Inhibition of colony formation in vitro by chloramphenicol correlates well with a dosedependent type of marrow depression in vivo, but does not explain why a few patients develop fatal marrow aplasia. If the latter were due to a biochemical cellular defect the dose-response curve for affected cells might be expected to be different from the dose-response curve for normal cells.
Serum concentrations of sodium aurothiomalate in patients with rheumatoid arthritis range between 5 and 40 pmol 1-in our laboratory, and colony formation in vitro is inhibited by drug concentrations within this range. Neutropenia secondary to chrysotherapy is uncommon, and on the basis of experiments reported elsewhere (Howell et al., 1973) , we have suggested that for the marked inhibitory effect of sodium aurothiomalate in agar culture is due either to inhibition of release of colony-stimulating factor from leucocytes in the agar under layer or due to the drug binding with colony-stimulating factor and rendering it inactive.
As expected of a drug which interferes with purine synthesis 6-mercaptopurine inhibits colony formation in vitro at low concentrations, but 2-amino-6-mercaptopurine (6-thioguanine) is ten times less active under similar culture conditions (A. Howell & R. 0. McKeran, unpublished observations) . Bone marrow culture may therefore be a useful way of testing different drugs with similar therapeutic effects for potential myelotoxicity.
Phenylbutazone, methimazole and thiouracil do not affect colony formation in the therapeutic range. These drugs may cause neutropenia in vivo because of an immunological reaction (Moeschlin, 1956; Huguenin, Albou & Griguer, 1959) ; under these circumstances they would not be expected to inhibit proliferation in vitro except possibly in the affected patients' serum.
As with many bioassays, considerable errors occur in estimating the parameters of the doseresponse curves, and it may be that the differences of effects of some drugs upon cells are too small to be demonstrated by assays of a practical size. Our evidence suggests, however, that detectable differences of response occur between mouse and human cells and between some related drugs with similar therapeutic effects, for example 6-mercaptopurine and 2-amino-6-mercaptopurine.
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